Weekly Recap: IMPAVIDO relaunch and leishmaniasis label with safety notes

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) has relaunched IMPAVIDO (miltefosine) in the U.S., distributing via Eton Cares, specialty distributors and hospital consignment to broaden rare—disease access while labeling it for visceral, cutaneous and mucosal leishmaniasis with embryo—fetal toxicity and…